Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              COVID-19 Antibody Response by Vaccine Type and Lymphocyte Count in RMS Patients on Ponesimod: Results From Phase 2 Long-term Extension Study AC-058B202

              Author:Wong, Janice   Hertoghs, Nina   Lemle, Alexandre   Linscheid, Philippe   Raghavan, Nandini   Singh, Amita   Sidorenko, Tatiana   

              Session Name:P12: MS COVID and Clinical Practice  

              Topic:MS and Inflammatory Disease  

              Program Number:P12.003  

              Author Institution:Janssen Research & Development, LLC, Titusville, United States, Titusville, NJ  Janssen Research & Development, LLC, Leiden, Netherlands, Leiden, Netherlands  Actelion Pharmaceuticals, Part of the Janssen Pharmaceutical Companies of Johnson & Johnson, Allschwil, Switzerland, Allschwil, Switzerland  Actelion Pharmaceuticals, Part of the Janssen Pharmaceutical Companies of Johnson & Johnson, Allschwil, Switzerland, Allschwil, Netherlands